- Home
- Research
- Neuroprotection
- Cannabidiol as an adjunct in refractory paroxysmal sympathetic hyperactivity following severe traumatic brain injury: a case report.
CBD offers hope for life-threatening brain injury complication
Cannabidiol as an adjunct in refractory paroxysmal sympathetic hyperactivity following severe traumatic brain injury: a case report.
AI Summary
Paroxysmal Sympathetic Hyperactivity (PSH) is a serious complication affecting 5-33% of severe traumatic brain injury (TBI) patients, causing dangerous episodes of rapid heart rate, extreme blood pressure spikes, and uncontrolled body movements. A 44-year-old patient with severe TBI developed severe PSH with 4-6 episodes daily despite treatment with seven different medications at maximum doses—making this a case of refractory PSH that had exhausted conventional treatment options.
When cannabidiol (CBD) was added as an adjunctive therapy at approximately 3 mg/kg/day, the results were striking: within the first week, episode frequency dropped from 4-6 daily to less than one per 48 hours, and severity scores dropped by 43%. By the second week, PSH episodes resolved completely, allowing doctors to discontinue powerful sedative and opioid infusions. Importantly, CBD was well-tolerated with no adverse effects, including no liver damage or excessive sedation.
While this is a single case report and cannot prove CBD causes the improvement, the dramatic response after conventional therapies failed suggests CBD's known neuroprotective and autonomic-modulating properties may offer new hope for TBI patients with refractory PSH. The findings warrant larger clinical trials to explore CBD's potential role in treating this life-threatening complication.
📄
Original Abstract
Related Research
Similar Studies
More Neuroprotection research papers you might find interesting.
Pilot study finds greater stress and dementia risk indicators in men
Review explores dual-action CB2 ligands for neurological disorders
Review links orexin and endocannabinoid signalling, but clinical value remains…
Explore More Research
Stay informed about the latest cannabis science.